Correlation Between Spero Therapeutics and Kiora Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Spero Therapeutics and Kiora Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spero Therapeutics and Kiora Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spero Therapeutics and Kiora Pharmaceuticals, you can compare the effects of market volatilities on Spero Therapeutics and Kiora Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spero Therapeutics with a short position of Kiora Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spero Therapeutics and Kiora Pharmaceuticals.
Diversification Opportunities for Spero Therapeutics and Kiora Pharmaceuticals
0.56 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Spero and Kiora is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Spero Therapeutics and Kiora Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kiora Pharmaceuticals and Spero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spero Therapeutics are associated (or correlated) with Kiora Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kiora Pharmaceuticals has no effect on the direction of Spero Therapeutics i.e., Spero Therapeutics and Kiora Pharmaceuticals go up and down completely randomly.
Pair Corralation between Spero Therapeutics and Kiora Pharmaceuticals
Given the investment horizon of 90 days Spero Therapeutics is expected to under-perform the Kiora Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Spero Therapeutics is 1.84 times less risky than Kiora Pharmaceuticals. The stock trades about -0.03 of its potential returns per unit of risk. The Kiora Pharmaceuticals is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 729.00 in Kiora Pharmaceuticals on August 31, 2024 and sell it today you would lose (403.00) from holding Kiora Pharmaceuticals or give up 55.28% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Spero Therapeutics vs. Kiora Pharmaceuticals
Performance |
| Timeline |
| Spero Therapeutics |
| Kiora Pharmaceuticals |
Spero Therapeutics and Kiora Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Spero Therapeutics and Kiora Pharmaceuticals
The main advantage of trading using opposite Spero Therapeutics and Kiora Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spero Therapeutics position performs unexpectedly, Kiora Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kiora Pharmaceuticals will offset losses from the drop in Kiora Pharmaceuticals' long position.| Spero Therapeutics vs. Assembly Biosciences | Spero Therapeutics vs. Achilles Therapeutics PLC | Spero Therapeutics vs. Instil Bio | Spero Therapeutics vs. CytomX Therapeutics |
| Kiora Pharmaceuticals vs. Virax Biolabs Group | Kiora Pharmaceuticals vs. Revelation Biosciences | Kiora Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Kiora Pharmaceuticals vs. Allarity Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |